TB Alliance And Rutgers University Announce Collaboration to Develop RNA Polymerase Inhibitors as New and Improved TB Treatments

TB Alliance -- The Global Alliance for TB Drug Development (TB Alliance) and Rutgers, The State University of New Jersey announced a collaboration to identify new small-molecule inhibitors of Mycobacterium tuberculosis RNA polymerase (RNAP) with the intent of developing new and improved TB treatments. The partnership will enable the TB Alliance to work with a research team led by Rutgers Professor and Howard Hughes Medical Institute Investigator, Dr. Richard Ebright.

Back to news